IU Undertakes $150M Initiative to Expand Translational, Personalized Medicine Programs | GenomeWeb

NEW YORK (GenomeWeb News) – Indiana University has launched a new $150 million, five-year effort that will use genetics and personalized medicine, among other approaches, to develop new capabilities and translational research projects focused on cancer, neuroscience, and cardiovascular medicine, the IU School of Medicine said on Thursday.

Under the plan, Indiana University Health, the school's healthcare system, and the Indiana University School of Medicine will each contribute $75 million in a joint research collaboration called the Strategic Research Initiative.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.